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Human herpesviruses (HHVs) are frequently considered 
as aetiological agents or cofactors in cutaneous diseases 
(1). However, clearly established HHV-7 associations 
are rare. We describe here a case in which diagnostic 
techniques led to viral detection and a better dermato-
logical diagnosis.
CASE REPORT
A 50-year-old man was referred to the department of 
dermatology with a diffuse erythemato-papular rash, 
spreading from the trunk to the limbs and neck, accom-
panied by intense pruritus (Fig. 1).
The patient’s medical history was unremarkable, no 
prodromal symptom was present, and he denied drug 
use, both routinely and in the days before the eruption. 
Laboratory investigations were negative or within normal 
ranges, except for mild lymphocytosis (3.9 × 103/mm3; 
normal range 1.5–3 × 103/mm3). A diagnosis of urticaria 
papulosa/insect bites was suspected.
The patient returned 3 days later due to persistent 
lesions. Skin biopsies were performed and the histolo-
gical findings showed an interface dermatitis, with rare 
lymphocytes along the dermo-epidermal junction, and 
a scarce, superficial perivascular lymphocytic infiltrate. 
The epidermis showed a mild spongiosis, lymphocytes 
exocytosis and rare single necrotic keratinocytes. No 
eosinophils were evident. An orthokeratotic stratum 
corneum with a preserved basket-weave aspect was 
seen, demonstrating the acute nature of the process 
(Fig. 2).
The most common infectious agents associated with 
cutaneous rashes (secondary syphilis, HSV 1–2, VZV, 
CMV, EBV, HHV-6, HCV, HBV, HIV, parvovirus B19, 
Coxsackie and echovirus) were excluded by serological 
testing or count of DNA copies in blood samples. The 
only notable finding was the detection of circulating 
HHV-7 DNA (800 copies/ml) in the blood, which is 
considered significant for active infection. A diagnosis 
of HHV-7 related papular rash was suggested.
Four weeks after the beginning of the eruption, the rash 
cleared completely without scaling and HHV-7 DNA was 
undetectable in blood samples.
DISCUSSION
HHV-7 was discovered in 1990 as a new member of the 
beta-herpesvirus subfamily. It is closely related to HHV-
6, sharing a strong genetic homology and the CD4+ cells 
tropism (1).
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Fig. 1. Erythematous papular eruption on the trunk.
Fig. 2. Histological examination of a papule: 
(a) An interface dermatitis, with lymphocytes 
along the dermo-epidermal junction, and a scarce, 
superficial, perivascular lymphocytic infiltrate 
(haematoxylin and eosin (H&E) ×10). (b) The 
epidermis shows a mild spongiosis, lymphocytes 
exocytosis and rare single necrotic keratinocytes. 
No eosinophils are evident. The stratum corneum 
is orthokeratotic, with a preserved basket-weave 
aspect (H&E ×40).
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Unlike HHV-6, HHV-7 does not integrate into the host 
DNA; thus, detection of HHV-7 DNA in patient blood 
using real time PCR implies active infection (1).
Primary infection occurs early in life and manifests 
as exanthema subitum, or other febrile illnesses mimick-
ing measles and rubella. According to serological studies, 
it is estimated that more than 90% of children up to the 
age of 5 years present with HHV-7 primary infection. 
Reactivation is extremely common and can be totally 
asymptomatic. HHV-7 has recently been identified as 
an emerging pathogen in transplant recipients and may 
exacerbate graft-versus-host disease (2, 3).
From a dermatological perspective, the possible as-
sociation of HHV-7 with pityriasis rosea has been a 
matter of discussion since 1997, when Rebora et al. (4) 
suggested a causative role of HHV-7 in the pathogenesis 
of the disease. Currently, the only cutaneous rash clearly 
associated with HHV-7 is exanthema subitum, which is 
also associated with HHV-6, although HHV-7 and HHV-
6 are also considered in the aetiology of lichen planus, 
graft-versus-host disease, recurrent vulvar ulcers and 
drug-induced hypersensitivity syndrome (5–7). 
Specific HHV-7 cutaneous papular rash has not been 
described so far; HHV-7 reactivation is often unapparent 
and asymptomatic, but the concomitant detection of 
HHV-7 DNA in the blood of a patient with cutaneous rash 
could be considered to be linked to the dermatological 
symptoms. Furthermore, the clinical remission of the 
skin eruption and the disappearance of HHV-7-DNA in 
the blood are indicative of a correlation.
The histopathological findings in our case exclude 
insect bites, but suggest viral rash and/or drug eruption. 
The patient denied drug intake, thus we correlate this 
papular rash with HHV-7 infection. 
In conclusion, although no specific treatment is known 
for many viral exanthemas, their recognition allows 
clinicians to differentiate such diagnoses from other cu-
taneous diseases and to provide more accurate answers 
to patients’ questions.
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